Dr Moulemanns also holds a PhD in insect cell biology. In these proceedings Dow has alleged that Professor Adang is a prior inventor of inventions the subject of Bayer patents. Professor Adang is a shareholder in the company. 23 I uphold Bayer's application. Dr Cusick comments on Dr Moulemanns' affidavit. However, upon the receiving party nominating an expert for this purpose the producing party may object to disclosure. This line of business will offer "Bt performance improvement technologies to the genetically modified crop protection trait markets". Deltapine does not wish to disclose Bayer's confidential documents to Professor Roush.